Ji-wan Seo

Title: Ji-wan Seo: Innovator in Cancer Treatment

Introduction

Ji-wan Seo is a prominent inventor based in Daegu, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a focus on biphenyl derivative compounds, his work aims to enhance cancer therapies and improve patient outcomes.

Latest Patents

Ji-wan Seo holds 2 patents related to biphenyl derivative compounds. His first patent, titled "Biphenyl derivative compound and use thereof," presents a novel biphenyl derivative compound that can induce cancer cell death by damaging mitochondria and inducing ATP depletion in nutrient-starved cells, which is characteristic of cancer cells. This compound also acts as an Nm23-H1/NDPK activity-increasing substance, potentially suppressing cancer metastasis and growth. His second patent similarly focuses on a biphenyl derivative compound that increases Nm23-H1/NDPK activity, further inhibiting cancer metastasis and growth. Both patents exhibit excellent effects on the prevention, alleviation, and treatment of cancer.

Career Highlights

Ji-wan Seo is affiliated with the Ewha University-Industry Collaboration Foundation, where he conducts his research and development. His work is characterized by a commitment to advancing cancer treatment methodologies through innovative compounds.

Collaborations

Ji-wan Seo collaborates with notable colleagues, including Kong Joo Lee and Hee-Yoon Lee, to further enhance the impact of his research in the field of oncology.

Conclusion

Ji-wan Seo's contributions to cancer treatment through his patented inventions highlight his role as a key innovator in the medical field. His research on biphenyl derivative compounds offers promising avenues for improving cancer therapies and patient care.